Adaptive Biotechnologies Corporation employees and revenue per employee

ADPT · Biotechnology · $4.52B market cap

Adaptive Biotechnologies Corporation had 624 employees at the end of fiscal Dec 2025, up 0.8% from a year earlier. Revenue for the year was $277M, up 54.8% from a year earlier, or $444K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

624

+0.8% YoY

Revenue

$277M

+54.8% YoY

Revenue / employee

$444K

Peer median $457K

Rank in industry

57 of 110

Biotechnology

Open roles

18

29 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2019
82213344'19'20'21'22'23'24'25Revenue 326Staff 138

Hover a year for the numbers.

ADPT employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025624$277M$444K+0.8%+54.8%
Dec 2024619$179M$289K-12.7%+5.1%
Dec 2023709$170M$240K-10.3%-8.1%
Dec 2022790$185M$235K-7.9%+20.1%
Dec 2021858$154M$180K+37.9%+56.9%
Dec 2020622$98.4M$158K+37.3%+15.6%
Dec 2019453$85.1M$188K——

Open roles on its job board: 18 (29 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years
622'20858'21790'22709'23619'24624'25
Revenue per employee, last six fiscal years
$158K'20$180K'21$235K'22$240K'23$289K'24$444K'25

Adaptive Biotechnologies Corporation against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
LGND
Ligand Pharmaceuticals Incorporated
47$268M$5.70MLeaner
RIGL
Rigel Pharmaceuticals, Inc.
172$294M$1.71MEfficient growth
CRMD
CorMedix Inc.
191$312M$1.63MEfficient growth
ARVN
Arvinas, Inc.
246$263M$1.07MContracting
VCEL
Vericel Corporation
398$276M$694KEfficient growth
XERS
Xeris Biopharma Holdings, Inc.
435$292M$671KEfficient growth
ADPT
Adaptive Biotechnologies Corporation
624$277M$444KEfficient growth
RCUS
Arcus Biosciences, Inc.
601$247M$411KContracting
IOVA
Iovance Biotherapeutics, Inc.
975$264M$270KEfficient growth
Every Healthcare company

Questions about Adaptive Biotechnologies Corporation

How many employees does Adaptive Biotechnologies Corporation have?
Adaptive Biotechnologies Corporation reported 624 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 0.8% from a year earlier.
What is Adaptive Biotechnologies Corporation's revenue per employee?
Adaptive Biotechnologies Corporation brought in $277M of revenue in fiscal Dec 2025, which is $444K per employee. That ranks 57 of 110 companies we track in Biotechnology, where the median is $457K.
Is Adaptive Biotechnologies Corporation hiring?
Adaptive Biotechnologies Corporation's public job board listed 18 open roles on November 20, 2026, about 29 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare ADPT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Adaptive Biotechnologies Corporation's annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell ADPT.